Skip to main content

Pharma

By Jessica Hagen | 11:39 am | January 12, 2023
The U.K.-based company will form an advanced clinical trials division offering digital health solutions for each phase of the development process.
By Jessica Hagen | 01:53 pm | January 11, 2023
Cuban tells MobiHealthNews that MCCPDC is working on adding partnerships with PBMs that "share our mission of cost-plus pricing, transparency and no rebates."
By HIMSS TV | 07:00 am | January 11, 2023
Dell Technologies wants to help healthcare providers in consolidating data. This enables access to precision medicine and supports strategies in cyber protection, says Wolfgang Mertz, CTO for Unstructured Data Solutions.
By Emily Olsen | 01:18 pm | January 05, 2023
The startup, which also announced a $3.4 million raise, aims to collect longitudinal patient data for research.
By HIMSS TV | 07:00 am | January 04, 2023
PharmStars founder and CEO Naomi Fried talks about the company's call for applications to digital health companies that aim to improve women's health and health equity for underserved populations.
By Emily Olsen | 11:57 am | December 30, 2022
According to the study published in npj Digital Medicine, high scores for depressive symptoms and lower-than-excellent self-rated health were associated with less smartwatch use.
By Emily Olsen | 11:07 am | December 30, 2022
Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.
By HIMSS TV | 07:00 am | December 30, 2022
The consortium's collaboration and partnership opportunities may be the most beneficial to the HIMSS audience, according to James Hury, the Translational Research Institute for Space Health's chief innovation officer.
By Jessica Hagen and Emily Olsen | 01:15 pm | December 28, 2022
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
By Jessica Hagen | 02:29 pm | December 19, 2022
The Drug Enforcement Administration says the digital pharmacy wrongfully distributed thousands of prescription stimulants for ADHD, including Adderall.